Davita (DVA) Shares Gain This Week: Will the Rally Continue?

Shares of DaVita Inc. (DVA) jumped this week, especially on Tuesday, following an announcement by Novo Nordisk (NVO) that its obesity treatment significantly lowered the mortality risk among patients with chronic kidney disease by 24%. However, the metric failed to cheer Novo Nordisk’s investors, driving dialysis provider DaVita’s shares along with other industry players like Fresenius Medical Care (FMS) Previously, Novo Nordisk halted the so-called FLOW study nearly a year ahead of schedule, achieving its ...